Advisor Group Holdings, Inc. Inmune Bio, Inc. Transaction History

Advisor Group Holdings, Inc.

  • $44.4 Billion
  • Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,850 shares of INMB stock, worth $6,897. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,850
Previous 13,925 79.53%
Holding current value
$6,897
Previous $108,000 94.44%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025
SELL
$2.31 - $8.26 $25,583 - $91,479
-11,075 Reduced 79.53%
2,850 $6,000
Q1 2025

May 12, 2025
BUY
$4.93 - $10.48 $57,311 - $121,830
11,625 Added 505.43%
13,925 $108,000
Q4 2024

Jun 06, 2025
SELL
$4.4 - $6.43 $51,150 - $74,748
-11,625 Reduced 83.48%
2,300 $10,000
Q4 2024

Feb 07, 2025
SELL
$4.4 - $6.43 $19,360 - $28,292
-4,400 Reduced 65.67%
2,300 $10,000
Q3 2024

Nov 13, 2024
SELL
$4.86 - $9.86 $7,110 - $14,425
-1,463 Reduced 17.92%
6,700 $36,000
Q2 2024

Aug 13, 2024
SELL
$7.15 - $11.84 $29,365 - $48,626
-4,107 Reduced 33.47%
8,163 $71,000
Q1 2024

May 10, 2024
BUY
$10.53 - $14.01 $16,532 - $21,995
1,570 Added 14.67%
12,270 $144,000
Q4 2023

Feb 12, 2024
BUY
$6.6 - $11.52 $14,520 - $25,344
2,200 Added 25.88%
10,700 $120,000
Q3 2023

Nov 13, 2023
SELL
$6.61 - $10.9 $17,847 - $29,430
-2,700 Reduced 24.11%
8,500 $57,000
Q2 2023

Aug 10, 2023
BUY
$6.5 - $10.09 $21,222 - $32,943
3,265 Added 41.15%
11,200 $101,000
Q1 2023

May 12, 2023
SELL
$6.01 - $10.18 $7,903 - $13,386
-1,315 Reduced 14.22%
7,935 $51,000
Q4 2022

Feb 10, 2023
BUY
$6.13 - $7.96 $19,616 - $25,472
3,200 Added 52.89%
9,250 $58,000
Q3 2022

Nov 14, 2022
BUY
$6.04 - $10.44 $2,977 - $5,146
493 Added 8.87%
6,050 $38,000
Q2 2022

Aug 10, 2022
SELL
$5.48 - $8.97 $150,935 - $247,060
-27,543 Reduced 83.21%
5,557 $49,000
Q1 2022

May 04, 2022
BUY
$6.42 - $11.39 $134,370 - $238,392
20,930 Added 171.98%
33,100 $279,000
Q3 2021

Nov 05, 2021
SELL
$14.13 - $27.85 $213,249 - $420,312
-15,092 Reduced 55.36%
12,170 $237,000
Q2 2021

Aug 02, 2021
BUY
$9.29 - $19.33 $179,111 - $372,682
19,280 Added 241.54%
27,262 $479,000
Q1 2021

May 13, 2021
BUY
$11.61 - $26.85 $23,011 - $53,216
1,982 Added 33.03%
7,982 $94,000
Q3 2020

Nov 12, 2020
BUY
$4.92 - $15.75 $28,536 - $91,350
5,800 Added 2900.0%
6,000 $62,000
Q2 2020

Aug 14, 2020
SELL
$3.1 - $6.09 $310 - $609
-100 Reduced 33.33%
200 $1,000
Q1 2020

May 18, 2020
BUY
$2.21 - $6.15 $663 - $1,845
300 New
300 $1,000

Others Institutions Holding INMB

# of Institutions
102
Shares Held
6.32M
Call Options Held
1.64M
Put Options Held
3.35M
View Full List

About Inmune Bio, Inc.

INMB Quotes by TradingView
  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $43.4M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email